[go: up one dir, main page]

NO20030978L - Behandling av urindysfunksjon - Google Patents

Behandling av urindysfunksjon

Info

Publication number
NO20030978L
NO20030978L NO20030978A NO20030978A NO20030978L NO 20030978 L NO20030978 L NO 20030978L NO 20030978 A NO20030978 A NO 20030978A NO 20030978 A NO20030978 A NO 20030978A NO 20030978 L NO20030978 L NO 20030978L
Authority
NO
Norway
Prior art keywords
treatment
urinary dysfunction
urinary
dysfunction
Prior art date
Application number
NO20030978A
Other languages
English (en)
Other versions
NO20030978D0 (no
Inventor
Julian Alexander Barden
Angus Gidley-Baird
Original Assignee
Intreat Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intreat Pty Ltd filed Critical Intreat Pty Ltd
Publication of NO20030978D0 publication Critical patent/NO20030978D0/no
Publication of NO20030978L publication Critical patent/NO20030978L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
NO20030978A 2000-08-28 2003-02-28 Behandling av urindysfunksjon NO20030978L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPQ9687A AUPQ968700A0 (en) 2000-08-28 2000-08-28 Treatment of urinary incontinence
PCT/AU2001/001079 WO2002017929A1 (en) 2000-08-28 2001-08-28 Treatment of urinary dysfunction

Publications (2)

Publication Number Publication Date
NO20030978D0 NO20030978D0 (no) 2003-02-28
NO20030978L true NO20030978L (no) 2003-04-16

Family

ID=3823741

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030978A NO20030978L (no) 2000-08-28 2003-02-28 Behandling av urindysfunksjon

Country Status (19)

Country Link
US (1) US20040067967A1 (no)
EP (1) EP1315503A4 (no)
JP (1) JP2004506744A (no)
KR (1) KR20030034162A (no)
CN (2) CN1479621A (no)
AU (1) AUPQ968700A0 (no)
BR (1) BR0113667A (no)
CA (1) CA2420846A1 (no)
CZ (1) CZ2003807A3 (no)
EA (1) EA007092B1 (no)
EE (1) EE200300082A (no)
HU (1) HUP0300860A3 (no)
IL (1) IL154642A0 (no)
MX (1) MXPA03001833A (no)
NO (1) NO20030978L (no)
NZ (1) NZ537643A (no)
PL (1) PL360368A1 (no)
WO (1) WO2002017929A1 (no)
ZA (1) ZA200302340B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005514940A (ja) * 2002-01-18 2005-05-26 ミレニアム・ファーマシューティカルズ・インコーポレイテッド １４３５分子、５５９分子、３４０２１分子、４４０９９分子、２５２７８分子、６４１分子、２６０分子、５５０８９分子、２１４０７分子、４２０３２分子、４６６５６分子、６２５５３分子、３０２分子、３２３分子、１２３０３分子、９８５分子、１３２３７分子、１３６０１分子、１８９２６分子、３１８分子、２０５８分子または６３５１分子を用いる泌尿器疾患を処置するための方法および組成物
US20050143323A1 (en) * 2003-12-30 2005-06-30 Henley E. C. Isoflavone therapy for treating urinary incontinence
KR100462173B1 (ko) * 2004-06-08 2004-12-16 안국약품 주식회사 요실금 예방 및 치료용 조성물
US20060039971A1 (en) * 2004-08-19 2006-02-23 Lee Robert E Effervescent composition including alternative hormone replacement therapy agent
WO2007020194A1 (en) * 2005-08-15 2007-02-22 F. Hoffmann-La Roche Ag Piperidine and piperazine derivatives as p2x3 antagonists
JP5193196B2 (ja) 2006-06-02 2013-05-08 ペア ツリー ウーマンズ ヘルス ケア 萎縮性膣炎の治療の方法
PL2343281T3 (pl) * 2006-10-04 2014-08-29 Hoffmann La Roche Sposób syntezy pochodnych fenoksydiaminopirymidyny
US8277426B2 (en) 2009-09-30 2012-10-02 Wilcox Heather J Male urinary incontinence device
WO2017041143A1 (en) 2015-09-11 2017-03-16 Ctm@Crc Ltd. Chimeric antigen receptors and uses thereof
JP7127021B2 (ja) 2016-10-21 2022-08-29 バイオセプター・（オーストラリア）・ピーティーワイ・リミテッド 細胞傷害性粒子
CN114502239B (zh) * 2019-10-02 2024-12-03 Aska制药株式会社 排尿障碍改善剂
WO2021065027A1 (ja) * 2019-10-02 2021-04-08 あすか製薬株式会社 排尿障害改善剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2566595A (en) * 1994-05-27 1995-12-21 Glaxo Group Limited P-2x receptors (purinoceptor family)
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
US5789442A (en) * 1996-01-18 1998-08-04 Schering Aktiengesellschaft Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents
AUPO203996A0 (en) * 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
US5856129A (en) * 1996-10-30 1999-01-05 Incyte Pharmaceuticals, Inc. DNA encoding a human purinoceptor

Also Published As

Publication number Publication date
CN1479621A (zh) 2004-03-03
JP2004506744A (ja) 2004-03-04
BR0113667A (pt) 2003-06-03
EA007092B1 (ru) 2006-06-30
KR20030034162A (ko) 2003-05-01
NO20030978D0 (no) 2003-02-28
NZ537643A (en) 2006-04-28
CA2420846A1 (en) 2002-03-07
EA200300264A1 (ru) 2003-10-30
PL360368A1 (en) 2004-09-06
US20040067967A1 (en) 2004-04-08
CZ2003807A3 (cs) 2003-08-13
ZA200302340B (en) 2004-06-28
AUPQ968700A0 (en) 2000-09-21
CN101164541A (zh) 2008-04-23
IL154642A0 (en) 2003-09-17
EP1315503A1 (en) 2003-06-04
WO2002017929A1 (en) 2002-03-07
MXPA03001833A (es) 2004-11-01
HUP0300860A2 (hu) 2003-11-28
HUP0300860A3 (en) 2005-03-29
EE200300082A (et) 2004-12-15
EP1315503A4 (en) 2005-02-09

Similar Documents

Publication Publication Date Title
NO20030230L (no) Behandling av jernsulfidavsetninger
DK1294644T3 (da) Vandbehandlingssammensætninger
EE200200571A (et) Hüdroksüfenüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks
NO20024486L (no) Forbedret behandling av neovaskularisering
NO20032122D0 (no) Forbedret behandling
NO20030978L (no) Behandling av urindysfunksjon
EE200200577A (et) Kinolinüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks
EE200200511A (et) Hüdroksüfenüülpiperasinüülmetüülbensamiidi derivaadid valu raviks
NO20024236D0 (no) Behandling av psoriasis
DE60103685D1 (de) Behandlung von Poriomania
NO20032156L (no) Behandling av angstforstyrrelser
PL362980A1 (en) Treatment of sexual dysfunction
NO20020369L (no) Sammensetninger for forebyggelse og behandling av nyredysfunksjoner og -sykdommer
ITMI20011820A0 (it) Trattamento di ustioni
NO20025765L (no) Kombinasjonssett for behandling av malaria
EP1303281A4 (en) METHODS OF TREATMENT
ATA10412001A (de) Kleinkläranlage
AU8160701A (en) Treatment of urinary dysfunction
EE200300379A (et) Alküülfenüüliminoimidasolidiini derivaadid uriinipidamatuse ravimiseks
EE200300177A (et) m-aminofenüüliminoimidasolidiinderivaadid uriinipidamatuse raviks
AU2001281607A1 (en) Treatment of urinary dysfunction
NO20014476D0 (no) Behandling av hiatial hernia
AU6191201A (en) Treatment of effluent
GB0014904D0 (en) Methods of treatment
GB0013928D0 (en) Methods of treatment

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application